These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21963966)

  • 1. [Optimization of antimicrobial therapy based on therapeutic drug monitoring].
    Morita K
    Yakugaku Zasshi; 2011; 131(10):1407-13. PubMed ID: 21963966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives.
    de Velde F; Mouton JW; de Winter BCM; van Gelder T; Koch BCP
    Pharmacol Res; 2018 Aug; 134():280-288. PubMed ID: 30033398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a prioritized scoring tool to improve time to pharmacist intervention.
    Harvin A; Mellett JJJ; Knoell D; Mirtallo J; Naseman RW; Brown N; Tubbs CR
    Am J Health Syst Pharm; 2018 Jan; 75(1):e50-e56. PubMed ID: 29273613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of factors in selecting anti-methicillin-resistant Staphylococcus aureus drugs by doctors].
    Hayashi H; Matsuzaki T; Saito A; Aoyama T; Matsumoto Y
    Yakugaku Zasshi; 2008 Jan; 128(1):81-7. PubMed ID: 18176058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scientific basis of treatment for infectious diseases--appropriate use of antibacterial agents based on PK-PD theory].
    Kizu J; Kuroda T
    Yakugaku Zasshi; 2011; 131(10):1401. PubMed ID: 21963964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical Approach to Individualization of Antimicrobial Therapy Based on Pharmacokinetic/Pharmacodynamic Analysis and Therapeutic Drug Monitoring].
    Sato Y; Suzuki Y; Tanaka R; Kaneko T; Itoh H
    Yakugaku Zasshi; 2019; 139(6):917-922. PubMed ID: 31155536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Optimization of Vancomycin Using a Mechanism-based Exposure-Response Model in Pediatric Infectious Disease Patients.
    Jung WJ; Park JH; Goo S; Chae JW; Kim J; Shin S; Yun HY
    Clin Ther; 2021 Jan; 43(1):185-194.e16. PubMed ID: 33358258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak M; Lomaestro B; Rotschafer JC; Moellering R; Craig W; Billeter M; Dalovisio JR; Levine DP
    Am J Health Syst Pharm; 2009 Jan; 66(1):82-98. PubMed ID: 19106348
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study.
    Lu H; Duan L; Yu Y; Li J; Shi L; Xue S; Zhang Q; Zhou Q; Zhu C; Shang E; Yan X; Tang L
    J Chemother; 2022 Nov; 34(7):446-458. PubMed ID: 35773225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of antimicrobial therapy in surgery.
    DiPiro JT; Edmiston CE; Bohnen JM
    Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing.
    Nakashima T; Koido K; Baba H; Otsuka R; Okinaka K; Sano T; Nishigaki R; Hashimoto H; Otsuka T; Esaki M; Terakado H
    Pharmazie; 2018 Jul; 73(7):422-424. PubMed ID: 30001779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.
    Scaglione F; Paraboni L
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.